Repository logo
 

Redevelopment of the Predict: Breast Cancer website and recommendations for developing interfaces to support decisionā€making

Published version
Peer-reviewed

Change log

Authors

Skylark, William J.  ORCID logo  https://orcid.org/0000-0002-3375-2669
Freeman, Alexandra L. J.  ORCID logo  https://orcid.org/0000-0002-4115-161X
Spiegelhalter, David J.  ORCID logo  https://orcid.org/0000-0001-9350-6745

Abstract

Abstract: Objectives: To develop a new interface for the widely used prognostic breast cancer tool: Predict: Breast Cancer. To facilitate decisionā€making around postā€surgery breast cancer treatments. To derive recommendations for communicating the outputs of prognostic models to patients and their clinicians. Method: We employed a userā€centred design process comprised of background research and iterative testing of prototypes with clinicians and patients. Methods included surveys, focus groups and usability testing. Results: The updated interface now caters to the needs of a wider audience through the addition of new visualisations, instantaneous updating of results, enhanced explanatory information and the addition of new predictors and outputs. A programme of future research was identified and is now underway, including the provision of quantitative data on the adverse effects of adjuvant breast cancer treatments. Based on our userā€centred design process, we identify six recommendations for communicating the outputs of prognostic models including the need to contextualise statistics, identify and address gaps in knowledge, and the critical importance of engaging with prospective users when designing communications. Conclusions: For prognostic algorithms to fulfil their potential to assist with decisionā€making they need carefully designed interfaces. Userā€centred design puts patients and clinicians needs at the forefront, allowing them to derive the maximum benefit from prognostic models.

Description

Funder: David and Claudia Harding Foundation

Keywords

ORIGINAL RESEARCH, breast cancer, cancer management, prognosis, risk assessment, translational research

Journal Title

Cancer Medicine

Conference Name

Journal ISSN

2045-7634

Volume Title

Publisher

Sponsorship
Wellcome ISSF (204796/Z/16/Z)